Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure

Bibliographic Details
Main Authors:	Patrick M. Honore, Leonel Barreto Gutierrez, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, David De Bels
Format:	Article
Language:	English
Published:	BMC 2020-08-01
Series:	Critical Care
Online Access:	http://link.springer.com/article/10.1186/s13054-020-03184-y

Similar Items

Inhibiting IL-6 in COVID-19: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-07-01)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-02-01)

The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Irrespective of the degree of hyperlactatemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with non-users: beware of confounders!
by: Patrick M. Honore, et al.
Published: (2020-10-01)

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
by: Patrick M. Honore, et al.
Published: (2020-07-01)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
by: Patrick M. Honore, et al.
Published: (2020-10-01)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
by: Patrick M. Honore, et al.
Published: (2020-07-01)

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Using indirect calorimetry in place of fixed energy prescription was feasible and energy targets were more closely met: do not forget an important limitation
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
by: Patrick M. Honore, et al.
Published: (2020-03-01)

500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?
by: Patrick M. Honore, et al.
Published: (2020-12-01)

High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Association between metformin use prior to admission and lower mortality in septic adult patients with diabetes mellitus: beware of potential confounders
by: Patrick M. Honore, et al.
Published: (2020-04-01)

With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Candida infections in severe acute pancreatitis: we need to do more in order to distinguish invasive infection from simple colonization
by: Patrick M. Honore, et al.
Published: (2020-04-01)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
by: Patrick M. Honore, et al.
Published: (2020-04-01)

Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
by: Patrick M. Honore, et al.
Published: (2020-04-01)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
by: Patrick M. Honore, et al.
Published: (2019-01-01)

Validity of the relationship between mobility group box-1 protein and poor post–cardiac arrest neurological outcome during renal replacement therapy
by: Patrick M. Honore, et al.
Published: (2019-03-01)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
by: Patrick M. Honore, et al.
Published: (2019-01-01)

Hyperchloremia-associated acute chronic kidney injury: beware of confounders!
by: Patrick M. Honore, et al.
Published: (2019-01-01)

Inducible metabolic pathway for citrate metabolism in case of major liver dysfunction: fact or fiction?
by: Patrick M. Honore, et al.
Published: (2019-05-01)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
by: Patrick M. Honore, et al.
Published: (2019-03-01)

Endovascular cooling is superior to surface cooling in terms of effectiveness by improving the neurological prognosis, but what about the safety?
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
by: Patrick M. Honore, et al.
Published: (2018-11-01)

New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
by: Patrick M. Honore, et al.
Published: (2020-02-01)